An Open-Label, Phase I Study to Assess the Pharmacokinetic Interaction Between Repeat Doses of Oral Casopitant and Intravenous and Oral Doses of Dexamethasone and Intravenous and Oral Doses of Ondansetron When Administered in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Casopitant (Primary) ; Dexamethasone; Dexamethasone; Ondansetron; Ondansetron
- Indications Cancer; Chemotherapy-induced nausea and vomiting; Postoperative nausea and vomiting
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 30 Jan 2008 Status changed from in progress to completed.
- 26 Sep 2007 Status change
- 23 Mar 2007 New trial record.